• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

光化性角化病管理指南:执行摘要。

Guidelines of care for the management of actinic keratosis: Executive summary.

机构信息

Department of Dermatology, University of California, Davis, Sacramento, California.

Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; Department of Population Medicine, Harvard Medical School, Boston, Massachusetts.

出版信息

J Am Acad Dermatol. 2021 Oct;85(4):945-955. doi: 10.1016/j.jaad.2021.05.056. Epub 2021 Jun 7.

DOI:10.1016/j.jaad.2021.05.056
PMID:34111497
Abstract

BACKGROUND

Actinic keratoses (AK) are rough scaly patches that arise on chronically ultraviolet-exposed skin and can progress to keratinocyte carcinoma. Treatment options for AK include topical medications, photodynamic therapy, cryosurgery, and laser ablation.

OBJECTIVE

This executive summary provides a synopsis of the 18 evidence-based recommendations for the treatment of AK detailed in the Guidelines of Care for the Management of Actinic Keratosis.

METHODS

A multidisciplinary workgroup conducted a systematic review to address 5 clinical questions on the management of AKs and applied the Grading of Recommendations Assessment, Development and Evaluation approach for assessing the certainty of the evidence and formulating and grading clinical recommendations. Graded recommendations were voted on to achieve consensus.

RESULTS

Analysis of the evidence resulted in 18 recommendations, suggesting there are several effective treatments available for AK.

LIMITATIONS

The analysis informing the recommendations was based on the best available evidence at the time it was conducted. The results of future studies may necessitate a revision of current recommendations.

CONCLUSIONS

Strong recommendations are presented for using ultraviolet protection, topical imiquimod, topical 5-fluorouracil, and cryosurgery. Conditional recommendations are presented for the use of photodynamic therapy and diclofenac for the treatment of AK, both individually and as part of combination therapy regimens.

摘要

背景

光化性角化病(AK)是在慢性暴露于紫外线的皮肤上出现的粗糙鳞片斑块,可能进展为角质形成细胞癌。AK 的治疗选择包括局部药物治疗、光动力疗法、冷冻疗法和激光消融。

目的

本执行摘要概述了《光化性角化病管理护理指南》中详细介绍的 18 项 AK 治疗的循证建议。

方法

一个多学科工作组进行了系统评价,以解决 AK 管理方面的 5 个临床问题,并应用评估建议、制定和分级临床建议的推荐分级评估、制定和评估方法来评估证据的确定性。对分级建议进行投票以达成共识。

结果

对证据的分析产生了 18 项建议,表明有几种有效的 AK 治疗方法。

局限性

为这些建议提供信息的分析是基于进行分析时可获得的最佳现有证据。未来的研究结果可能需要对当前的建议进行修订。

结论

强烈建议使用紫外线防护、局部咪喹莫特、局部 5-氟尿嘧啶和冷冻疗法。有条件地建议使用光动力疗法和双氯芬酸治疗 AK,单独使用或作为联合治疗方案的一部分。

相似文献

1
Guidelines of care for the management of actinic keratosis: Executive summary.光化性角化病管理指南:执行摘要。
J Am Acad Dermatol. 2021 Oct;85(4):945-955. doi: 10.1016/j.jaad.2021.05.056. Epub 2021 Jun 7.
2
Guidelines of care for the management of actinic keratosis.光化性角化病治疗管理指南。
J Am Acad Dermatol. 2021 Oct;85(4):e209-e233. doi: 10.1016/j.jaad.2021.02.082. Epub 2021 Apr 2.
3
Interventions for actinic keratoses.光化性角化病的干预措施。
Cochrane Database Syst Rev. 2012 Dec 12;12(12):CD004415. doi: 10.1002/14651858.CD004415.pub2.
4
Evaluation of Long-term Clearance Rates of Interventions for Actinic Keratosis: A Systematic Review and Network Meta-analysis.评价光化性角化病干预措施的长期清除率:系统评价和网络荟萃分析。
JAMA Dermatol. 2021 Sep 1;157(9):1066-1077. doi: 10.1001/jamadermatol.2021.2779.
5
Long-term efficacy of interventions for actinic keratosis: protocol for a systematic review and network meta-analysis.长期干预光化性角化病的疗效:系统评价和网络荟萃分析方案。
Syst Rev. 2019 Oct 11;8(1):237. doi: 10.1186/s13643-019-1156-8.
6
Artificial daylight photodynamic therapy using methyl aminolaevulinate in a real-world setting in Germany: results from the noninterventional study ArtLight.德国真实环境中使用甲基氨基乙酰丙酸的人工日光光动力疗法:非干预性研究ArtLight的结果
Br J Dermatol. 2025 Feb 18;192(3):510-519. doi: 10.1093/bjd/ljae437.
7
Treatment of actinic keratosis: a systematic review.光化性角化病的治疗:系统评价。
Arch Dermatol Res. 2023 Jul;315(5):1099-1108. doi: 10.1007/s00403-022-02490-5. Epub 2022 Dec 1.
8
A network meta-analysis of the relative efficacy of treatments for actinic keratosis of the face or scalp in Europe.欧洲面部或头皮光化性角化病治疗相对疗效的网状Meta分析。
PLoS One. 2014 Jun 3;9(6):e96829. doi: 10.1371/journal.pone.0096829. eCollection 2014.
9
Topical Calcipotriol Plus 5-Fluorouracil in the Treatment of Actinic Keratosis, Bowen's Disease, and Squamous Cell Carcinoma: A Systematic Review.局部钙泊三醇联合 5-氟尿嘧啶治疗光化性角化病、鲍恩病和鳞状细胞癌:系统评价。
J Cutan Med Surg. 2024 Jul-Aug;28(4):375-380. doi: 10.1177/12034754241256347. Epub 2024 May 23.
10
Efficacy of Photodynamic Therapy in the Treatment of Actinic Keratosis: A Network Meta-Analysis.光动力疗法治疗光化性角化病的疗效:网络荟萃分析。
J Cutan Med Surg. 2024 Nov-Dec;28(6):536-542. doi: 10.1177/12034754241266177. Epub 2024 Aug 5.

引用本文的文献

1
Prevalence of head and face actinic keratosis among older community residents aged ≥60 years in Shanghai: a cross-sectional study.上海≥60岁老年社区居民头面部光化性角化病患病率:一项横断面研究。
Front Med (Lausanne). 2025 Aug 11;12:1558683. doi: 10.3389/fmed.2025.1558683. eCollection 2025.
2
Tirbanibulin 1% Ointment for the Treatment of Hyperkeratotic Actinic Keratosis.1%替拉替尼软膏治疗角化过度型光化性角化病
J Dermatol. 2025 Jul 2. doi: 10.1111/1346-8138.17845.
3
Daylight Photodynamic Therapy for Actinic Keratosis and Field Cancerization: A Narrative Review.

本文引用的文献

1
Guidelines of care for the management of actinic keratosis.光化性角化病治疗管理指南。
J Am Acad Dermatol. 2021 Oct;85(4):e209-e233. doi: 10.1016/j.jaad.2021.02.082. Epub 2021 Apr 2.
2
Cutaneous Squamous Cell Carcinoma in Immunosuppressed Patients.免疫抑制患者的皮肤鳞状细胞癌。
Curr Oncol Rep. 2019 Jul 29;21(9):82. doi: 10.1007/s11912-019-0831-1.
3
Conventional versus daylight photodynamic therapy for actinic keratosis: A randomized and prospective study in China.常规与日光光动力疗法治疗光化性角化病:中国一项随机前瞻性研究。
日光光动力疗法治疗光化性角化病和场癌化:一项叙述性综述
Cancers (Basel). 2025 Mar 20;17(6):1050. doi: 10.3390/cancers17061050.
4
Prebiotic- and Panthenol-Containing Multipurpose Healing Dermocosmetics Post-Cryotherapy for Actinic Keratoses: Results of a Randomized Controlled Trial.含益生元和泛醇的多功能愈合皮肤化妆品用于光化性角化病冷冻治疗后:一项随机对照试验的结果
Dermatol Pract Concept. 2025 Jan 30;15(1):4905. doi: 10.5826/dpc.1501a4905.
5
Long-term follow-up of a randomized, double-blind, phase III, multi-centre study to evaluate the safety and efficacy of field-directed photodynamic therapy (PDT) of mild to moderate actinic keratosis using BF-200 ALA versus placebo and the BF-RhodoLED® lamp.一项随机、双盲、III期、多中心研究的长期随访,该研究旨在评估使用BF-200 ALA对比安慰剂及BF-RhodoLED®灯对轻度至中度光化性角化病进行病灶定向光动力疗法(PDT)的安全性和有效性。
J Eur Acad Dermatol Venereol. 2024 Dec 12. doi: 10.1111/jdv.20452.
6
Tirbanibulin 1% Ointment for Actinic Keratosis: Results from a Real-Life Study.他扎罗汀 1% 乳膏治疗光化性角化病:真实世界研究结果。
Medicina (Kaunas). 2024 Jan 28;60(2):225. doi: 10.3390/medicina60020225.
7
Preliminary Evidence of Efficacy, Safety, and Treatment Satisfaction with Tirbanibulin 1% Ointment: A Clinical Perspective on Actinic Keratoses.1%替拉替尼软膏疗效、安全性及治疗满意度的初步证据:光化性角化病的临床视角
Pharmaceuticals (Basel). 2023 Dec 4;16(12):1686. doi: 10.3390/ph16121686.
8
Photodynamic Therapy is an Effective Treatment of Facial Pigmented Actinic Keratosis.光动力疗法是治疗面部色素性光化性角化病的有效方法。
Dermatol Ther (Heidelb). 2023 Jun;13(6):1265-1276. doi: 10.1007/s13555-023-00924-0. Epub 2023 May 10.
9
Treatment of Actinic Keratosis: The Best Choice through an Observational Study.光化性角化病的治疗:一项观察性研究中的最佳选择
J Clin Med. 2022 Jul 7;11(14):3953. doi: 10.3390/jcm11143953.
Photodiagnosis Photodyn Ther. 2018 Dec;24:366-371. doi: 10.1016/j.pdpdt.2018.10.010. Epub 2018 Oct 15.
4
Safety and Efficacy of Escalating Doses of Ingenol Mebutate for Field Treatment of Actinic Keratosis on the Full Face, Full Balding Scalp, or Chest.逐步递增剂量的鬼臼毒素丁酯用于全脸、全秃头皮或胸部光化性角化病现场治疗的安全性和有效性
J Drugs Dermatol. 2017 May 1;16(5):438-444.
5
Assessment of Efficacy and Irritation of Ingenol Mebutate Gel 0.015% Used With or Without Dimethicone Lotion for Treatment of Actinic Keratosis on the Face.评估0.015% 鬼臼毒素丁酯凝胶联合或不联合二甲基硅油洗剂治疗面部光化性角化病的疗效和刺激性。
J Drugs Dermatol. 2017 May 1;16(5):432-436.
6
The importance of treating the field in actinic keratosis.重视光化性角化病的治疗。
J Eur Acad Dermatol Venereol. 2017 Mar;31 Suppl 2:8-11. doi: 10.1111/jdv.14092.
7
Randomized controlled trial comparing 35% trichloroacetic acid peel and 5-aminolaevulinic acid photodynamic therapy for treating multiple actinic keratosis.随机对照试验比较 35%三氯乙酸剥脱术和 5-氨基酮戊酸光动力疗法治疗多发性光化性角化病。
Br J Dermatol. 2017 May;176(5):1155-1161. doi: 10.1111/bjd.15272. Epub 2017 Apr 5.
8
Randomized trial of calcipotriol combined with 5-fluorouracil for skin cancer precursor immunotherapy.骨化三醇联合5-氟尿嘧啶用于皮肤癌前病变免疫治疗的随机试验
J Clin Invest. 2017 Jan 3;127(1):106-116. doi: 10.1172/JCI89820. Epub 2016 Nov 21.
9
Guideline panels should seldom make good practice statements: guidance from the GRADE Working Group.指南小组应极少制定良好实践声明:来自GRADE工作组的指导意见。
J Clin Epidemiol. 2016 Dec;80:3-7. doi: 10.1016/j.jclinepi.2016.07.006. Epub 2016 Jul 22.
10
A randomized, double-blind, phase III, multicentre study to evaluate the safety and efficacy of BF-200 ALA (Ameluz(®) ) vs. placebo in the field-directed treatment of mild-to-moderate actinic keratosis with photodynamic therapy (PDT) when using the BF-RhodoLED(®) lamp.一项随机、双盲、III 期、多中心研究,旨在评估 BF-200 ALA(Ameluz(®))与安慰剂在使用 BF-RhodoLED(®)灯进行光动力疗法(PDT)治疗轻度至中度光化性角化病时的安全性和疗效。
Br J Dermatol. 2016 Oct;175(4):696-705. doi: 10.1111/bjd.14498. Epub 2016 Jun 25.